Welcome!

News Feed Item

India Orthobiologics Market Outlook to 2020

NEW YORK, March 11, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

India Orthobiologics Market Outlook to 2020
http://www.reportlinker.com/p02043354/India-Orthobiologics-Market-Outlook-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

India Orthobiologics Market Outlook to 2020

Summary

GlobalData's new report, "India Orthobiologics Market Outlook to 2020", provides key market data on the India Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the India Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc., Stryker Corporation and Alphatec Holdings, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Orthobiologics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Orthobiologics Market, India 7
3.1 Orthobiologics Market, India, Revenue ($m), 2005-2012 7
3.2 Orthobiologics Market, India, Revenue ($m), 2012-2020 9
3.2.1 Bone Graft Substitutes Market, India, Revenue ($m), by Segment, 2005-2012 11
3.2.2 Bone Graft Substitutes Market, India, Revenue ($m), by Segment, 2012-2020 13
3.3 Orthobiologics Market, India, Volume (Units), 2005-2012 15
3.4 Orthobiologics Market, India, Volume (Units), 2012-2020 17
3.4.1 Bone Graft Substitutes Market, India, Volume (Units), by Segment, 2005-2012 19
3.4.2 Bone Graft Substitutes Market, India, Volume (Units), by Segment, 2012-2020 21
3.5 Orthobiologics Market, India, Average Price ($), 2005-2020 23
3.6 Orthobiologics Market, India, Distribution Share by Revenue ($m), 2011-2012 25
3.7 Orthobiologics Market, India, Company Share by Revenue ($m), 2011-2012 26
4 Overview of Key Companies in India Orthobiologics Market 28
4.1 DePuy Companies 28
4.1.1 Company Overview 28
4.2 Sanofi 28
4.2.1 Company Overview 28
4.3 Baxter International Inc. 28
4.3.1 Company Overview 28
4.4 Medtronic, Inc. 29
4.4.1 Company Overview 29
4.5 Orthofix International N.V. 29
4.5.1 Company Overview 29
4.6 Biomet, Inc. 30
4.6.1 Company Overview 30
4.7 Smith & Nephew Plc 30
4.7.1 Company Overview 30
4.8 Wright Medical Group, Inc. 30
4.8.1 Company Overview 30
4.9 Stryker Corporation 31
4.9.1 Company Overview 31
5 Orthobiologics Market Pipeline Products 32
6 Financial Deals Landscape 34
6.1 Asset Transactions 34
6.1.1 Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 34
6.2 Partnerships 36
6.2.1 Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital 36
6.2.2 aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 37
7 Appendix 38
7.1 Research Methodology 39
7.1.1 Coverage 39
7.1.2 Secondary Research 39
7.1.3 Primary Research 40
7.1.4 Market Modeling and Forecasting 41
7.1.5 Company Share Analysis 44
7.1.6 Distribution Share Analysis 45
7.2 Expert Panel 46
7.3 GlobalData Consulting 46
7.4 Contact Us 46
7.5 Disclaimer 46

List of Tables

Table 1: Orthobiologics Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 8
Table 2: Orthobiologics Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 10
Table 3: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 12
Table 4: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 14
Table 5: Orthobiologics Market, India, Volume (Units), Historic, 2005-2012 16
Table 6: Orthobiologics Market, India, Volume (Units), Forecast, 2012-2020 18
Table 7: Bone Graft Substitutes Market, India, Volume (Units), Historic, 2005-2012 20
Table 8: Bone Graft Substitutes Market, India, Volume (Units), Forecast, 2012-2020 22
Table 9: Orthobiologics Market, India, Average Price ($), Historic, 2005-2012 23
Table 10: Orthobiologics Market, India, Average Price ($), Forecast, 2012-2020 24
Table 11: Orthobiologics Market, India, Distribution Share by Revenue ($m), USD Constant, 2011-2012 25
Table 12: Orthobiologics Market, India, Company Share by Revenue ($m), USD Constant, 2011-2012 27
Table 13: Orthobiologics Market Pipeline Products 32
Table 14: Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 34
Table 15: Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital 36
Table 16: aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 37
Table 17: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 41

List of Figures

Figure 1: Orthobiologics Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 7
Figure 2: Orthobiologics Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 9
Figure 3: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 11
Figure 4: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 13
Figure 5: Orthobiologics Market, India, Volume (Units), Historic, 2005-2012 15
Figure 6: Orthobiologics Market, India, Volume (Units), Forecast, 2012-2020 17
Figure 7: Bone Graft Substitutes Market, India, Volume (Units), Historic, 2005-2012 19
Figure 8: Bone Graft Substitutes Market, India, Volume (Units), Forecast, 2012-2020 21
Figure 9: Orthobiologics Market, India, Company Share (%), 2012 26
Figure 10: GlobalData Epidemiology-Based Forecasting Model 43
Figure 11: GlobalData Capital Equipment-Based Forecasting Model 44
Figure 12: Primary Interviews by Participant Type (%) 45

To order this report: India Orthobiologics Market Outlook to 2020
http://www.reportlinker.com/p02043354/India-Orthobiologics-Market-Outlook-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Keisoku Research Consultant Co. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Keisoku Research Consultant, Co. offers research and consulting in a wide range of civil engineering-related fields from information construction to preservation of cultural properties. For more information, vi...
SYS-CON Events announced today that Interface Corporation will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Interface Corporation is a company developing, manufacturing and marketing high quality and wide variety of industrial computers and interface modules such as PCIs and PCI express. For more information, visit http://www.i...
SYS-CON Events announced today that Fusic will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Fusic Co. provides mocks as virtual IoT devices. You can customize mocks, and get any amount of data at any time in your test. For more information, visit https://fusic.co.jp/english/.
With the rise of DevOps, containers are at the brink of becoming a pervasive technology in Enterprise IT to accelerate application delivery for the business. When it comes to adopting containers in the enterprise, security is the highest adoption barrier. Is your organization ready to address the security risks with containers for your DevOps environment? In his session at @DevOpsSummit at 21st Cloud Expo, Chris Van Tuin, Chief Technologist, NA West at Red Hat, will discuss: The top security r...
SYS-CON Events announced today that TMC has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo and Big Data at Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Global buyers rely on TMC’s content-driven marketplaces to make purchase decisions and navigate markets. Learn how we can help you reach your marketing goals.
SYS-CON Events announced today that Enroute Lab will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Enroute Lab is an industrial design, research and development company of unmanned robotic vehicle system. For more information, please visit http://elab.co.jp/.
Why Federal cloud? What is in Federal Clouds and integrations? This session will identify the process and the FedRAMP initiative. But is it sufficient? What is the remedy for keeping abreast of cutting-edge technology? In his session at 21st Cloud Expo, Rasananda Behera will examine the proposed solutions: Private or public or hybrid cloud Responsible governing bodies How can we accomplish?
Cloud-based disaster recovery is critical to any production environment and is a high priority for many enterprise organizations today. Nearly 40% of organizations have had to execute their BCDR plan due to a service disruption in the past two years. Zerto on IBM Cloud offer VMware and Microsoft customers simple, automated recovery of on-premise VMware and Microsoft workloads to IBM Cloud data centers.
There is huge complexity in implementing a successful digital business that requires efficient on-premise and cloud back-end infrastructure, IT and Internet of Things (IoT) data, analytics, Machine Learning, Artificial Intelligence (AI) and Digital Applications. In the data center alone, there are physical and virtual infrastructures, multiple operating systems, multiple applications and new and emerging business and technological paradigms such as cloud computing and XaaS. And then there are pe...
SYS-CON Events announced today that Daiya Industry will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Daiya Industry specializes in orthotic support systems and assistive devices with pneumatic artificial muscles in order to contribute to an extended healthy life expectancy. For more information, please visit https://www.daiyak...
Real IoT production deployments running at scale are collecting sensor data from hundreds / thousands / millions of devices. The goal is to take business-critical actions on the real-time data and find insights from stored datasets. In his session at @ThingsExpo, John Walicki, Watson IoT Developer Advocate at IBM Cloud, will provide a fast-paced developer journey that follows the IoT sensor data from generation, to edge gateway, to edge analytics, to encryption, to the IBM Bluemix cloud, to Wa...
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists examined how DevOps helps to meet the de...
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...
The last two years has seen discussions about cloud computing evolve from the public / private / hybrid split to the reality that most enterprises will be creating a complex, multi-cloud strategy. Companies are wary of committing all of their resources to a single cloud, and instead are choosing to spread the risk – and the benefits – of cloud computing across multiple providers and internal infrastructures, as they follow their business needs. Will this approach be successful? How large is the ...
Enterprises are moving to the cloud faster than most of us in security expected. CIOs are going from 0 to 100 in cloud adoption and leaving security teams in the dust. Once cloud is part of an enterprise stack, it’s unclear who has responsibility for the protection of applications, services, and data. When cloud breaches occur, whether active compromise or a publicly accessible database, the blame must fall on both service providers and users. In his session at 21st Cloud Expo, Ben Johnson, C...